CN107158249A - 健脑通络酒及其制备方法 - Google Patents
健脑通络酒及其制备方法 Download PDFInfo
- Publication number
- CN107158249A CN107158249A CN201710509863.5A CN201710509863A CN107158249A CN 107158249 A CN107158249 A CN 107158249A CN 201710509863 A CN201710509863 A CN 201710509863A CN 107158249 A CN107158249 A CN 107158249A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- blood
- wine
- function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000014101 wine Nutrition 0.000 title claims abstract description 44
- 210000004556 brain Anatomy 0.000 title claims abstract description 37
- 230000001256 tonic effect Effects 0.000 title claims abstract description 29
- 210000003462 vein Anatomy 0.000 title claims abstract description 27
- 230000002040 relaxant effect Effects 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- 241000545744 Hirudinea Species 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 13
- 239000011435 rock Substances 0.000 claims abstract description 13
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 12
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 12
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 12
- 240000004638 Dendrobium nobile Species 0.000 claims abstract description 11
- 235000003365 Ilex pubescens Nutrition 0.000 claims abstract description 11
- 241001100932 Ilex pubescens Species 0.000 claims abstract description 11
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 11
- 241000521581 Millettia Species 0.000 claims abstract description 11
- 241001061906 Caragana Species 0.000 claims abstract description 10
- 240000008669 Hedera helix Species 0.000 claims abstract description 10
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 10
- 235000005412 red sage Nutrition 0.000 claims abstract description 10
- 240000000920 Typhonium flagelliforme Species 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims description 9
- 235000013339 cereals Nutrition 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 235000019991 rice wine Nutrition 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 238000005352 clarification Methods 0.000 claims description 3
- 238000007803 cold maceration Methods 0.000 claims description 3
- 238000005336 cracking Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 235000019633 pungent taste Nutrition 0.000 claims description 3
- 241001163113 Photinia glabra Species 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 18
- 230000000302 ischemic effect Effects 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 description 95
- 239000008280 blood Substances 0.000 description 92
- 230000006870 function Effects 0.000 description 41
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 32
- 201000010099 disease Diseases 0.000 description 25
- 239000003814 drug Substances 0.000 description 25
- 230000017531 blood circulation Effects 0.000 description 24
- 235000015961 tonic Nutrition 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 23
- 206010062717 Increased upper airway secretion Diseases 0.000 description 21
- 230000000694 effects Effects 0.000 description 21
- 230000036407 pain Effects 0.000 description 21
- 208000026435 phlegm Diseases 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 15
- 244000131316 Panax pseudoginseng Species 0.000 description 14
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 13
- 230000007812 deficiency Effects 0.000 description 13
- 206010008190 Cerebrovascular accident Diseases 0.000 description 12
- 208000006011 Stroke Diseases 0.000 description 12
- 210000003414 extremity Anatomy 0.000 description 11
- 239000007789 gas Substances 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 10
- 230000023597 hemostasis Effects 0.000 description 10
- 208000034783 hypoesthesia Diseases 0.000 description 10
- 206010019468 Hemiplegia Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 231100000862 numbness Toxicity 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 8
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 8
- 208000029078 coronary artery disease Diseases 0.000 description 8
- 208000014674 injury Diseases 0.000 description 8
- 210000004204 blood vessel Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 208000031225 myocardial ischemia Diseases 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 206010002383 Angina Pectoris Diseases 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 239000000306 component Substances 0.000 description 6
- 230000002950 deficient Effects 0.000 description 6
- 230000002526 effect on cardiovascular system Effects 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 241000427159 Achyranthes Species 0.000 description 5
- 206010008132 Cerebral thrombosis Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 208000034158 bleeding Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 210000001627 cerebral artery Anatomy 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 230000004089 microcirculation Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 210000002105 tongue Anatomy 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000004044 Hypesthesia Diseases 0.000 description 3
- 206010061216 Infarction Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000180649 Panax notoginseng Species 0.000 description 3
- 235000003143 Panax notoginseng Nutrition 0.000 description 3
- 241000405414 Rehmannia Species 0.000 description 3
- 208000032109 Transient ischaemic attack Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003288 anthiarrhythmic effect Effects 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 206010008118 cerebral infarction Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000007574 infarction Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 230000002537 thrombolytic effect Effects 0.000 description 3
- 201000010875 transient cerebral ischemia Diseases 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- 206010008088 Cerebral artery embolism Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010019452 Hemianopia Diseases 0.000 description 2
- 208000007460 Hemianopsia Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 201000007201 aphasia Diseases 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000004413 cardiac myocyte Anatomy 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 201000010849 intracranial embolism Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000008336 microcirculatory blood flow Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- KRQUFUKTQHISJB-YYADALCUSA-N 2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one Chemical compound CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1 KRQUFUKTQHISJB-YYADALCUSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 208000025940 Back injury Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 235000006463 Brassica alba Nutrition 0.000 description 1
- 244000140786 Brassica hirta Species 0.000 description 1
- 235000011371 Brassica hirta Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- 208000027932 Collagen disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 235000003325 Ilex Nutrition 0.000 description 1
- 241000209035 Ilex Species 0.000 description 1
- 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 1
- 206010025391 Macroglossia Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000008601 Polycythemia Diseases 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 101000712605 Theromyzon tessulatum Theromin Proteins 0.000 description 1
- 229940122388 Thrombin inhibitor Drugs 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000028938 Urination disease Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 201000004810 Vascular dementia Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
- 206010003230 arteritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- -1 blockage of vessel Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000003683 cardiac damage Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 1
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 210000004298 cerebral vein Anatomy 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003868 thrombin inhibitor Substances 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 238000007395 thrombosis prophylaxis Methods 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000009530 yishen Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
健脑通络酒及其制备方法。本发明组成包括重量份数为300的常青藤、重量份数为300的毛冬青、重量份数为300的锦鸡儿、重量份数为300的鸡血藤、重量份数为260的丹参、重量份数为260的当归、重量份数为200的西洋参、重量份数为300的熟地、重量份数为150的田三七、重量份数为260的石斛、重量份数为300的石楠叶、重量份数为200的川芎、重量份数为260的怀牛膝、重量份数为150的土鳖虫、重量份数为150的地龙、重量份数为100的水蛭、重量份数为200的白芥子、重量份数为300的葛根、重量份数为27000的纯粮酒、重量份数为2500的冰糖。本发明用于预防缺血性脑血管病的中药酒。
Description
技术领域:
本发明涉及一种纯中药制备的健脑、通络、消栓、溶脂、预防中风偏瘫的酒,预防缺血性脑血管病形成的功能性保健酒。
背景技术:
目前我国每年死于心脑梗塞的患者近600~700万人,另有上千万人因心脑血管病处于脑动脉内膜病变,由心脑动脉硬化,引起的管腔狭窄,血液成份改变以及血流缓慢而导致血管闭塞,逐渐脑血栓形成,使病变血管发生梗塞,局部水肿,周围组织充血、肿胀、缺血坏死,形成缺血性脑血管病:肢体麻木、半身瘫痪、口舌斜、偏盲、失语、痴呆……生活在半残疾状态之中,苦不堪言。
心脑血管病在我国处于患病率高、死亡率高、致残率高的三高态势。惨痛的事实告诉我们,防范于未然,预防血栓的发生,才能挽救致病、致残、致死的患者。本发明健脑通络酒,可全面控制心脑血管疾病的发生,发展及复发,起到积极预防作用。
中医对“缺血性脑血管病”的认识,历史悠久,经验丰富。从广义上讲包括脑梗塞、脑血栓和短暂性脑缺血发作,重者出血、缺血致复合性中风。一般认为,多为50岁以后起病,男性较多,主要为脑动脉内膜病变,由动脉硬化(偏瘫、全瘫)或高血压病,或脑部各种感染、头颈部外伤、红细胞增多症等,引起血管腔狭窄,血液成分改变以及血流缓慢,而导致血管闭塞所出现的偏瘫等神经症状。脑血栓形成后,病变血管所供养的脑组织发生梗塞,局部水肿,周围组织充血,渐至肿胀、缺血坏死和软化,甚至形成出血性梗塞,并可留下疤痕组织。然而,50岁以前患有心力衰竭、心肌梗死、心律失常、休克、晕厥、失水、产后出血、疲劳和睡眠以及胶原性疾病、各种动脉炎的年轻病人,也可发生本病。中医认为因瘀痰入脉,阻塞脑络所致;属于以半身不遂、口舌斜、偏盲、失语等主要表现的脑血管病变,名之“缺血性中风”。此病以高发病率、高死亡率、高致残率,严重危害人类健康。
中风先兆几种体征
1、头昏脑胀:突然感到头昏目眩,视物旋转,头脑发胀,头重脚轻,脚底如踏棉絮,摇晃不稳。
、肢体麻木:突然感到一侧肢体麻木,软弱无力,或手指麻木,尤其常见大、中指麻木,或一侧肢体有蚁行感。
、头痛头闷:突然出现异于一般的头痛头闷,或头沉难举。
、说话不利:突然发生说话不利,或嘴角抽动,口角流涎,舌体肥大或歪斜。
、耳鸣耳聋:突然耳如蝉鸣,耳内阻塞迫胀,听力障碍。
、神疲嗜睡:突然出现全身异常疲惫,或没有明显原因的嗜睡不醒。
、高血压患者,每日或2~3日1次,自觉一侧或两侧肢体麻木,肌肉抽动,挛急,或知觉减退者。
、体质肥胖且有高血压,时作恶心感,自觉口中粘腻,或不自主口角流涎,嗜睡。
以上种种迹象,有的单独发生,有的二三种并发,皆为中风先兆症候,提示人们当引起重视,可服用《健脑通络酒药》达到防病于未然。
中风先兆亦称小中风,现代医学称为短暂性脑缺血发作。古今医家多以中风证的“风中经络”,“虚、火、风、痰、瘀”立论,临床实践证明,其主要病机是“痰瘀阻络(脑络)”。因人到中年由壮减弱,精血耗损,或肾水亏损,水不涵木;或脾失健运,聚湿生痰;或气虚血瘀,脉络瘀阻,皆是发于痰之“机因”。劳累过度,事不遂心,纵欲无度,过食肥甘等,均可致使气血逆乱,上扰清窍,横窜经遂,脉络(脑络)受阻而诱发此病。
发明内容:
本发明的目的是提供一种健脑通络酒及其制备方法,预防中风偏瘫、预防缺血性脑血管病的药酒。
一种健脑通络酒,其组成包括重量份数为290-310的常青藤、重量份数为290-310的毛冬青、重量份数为290-310的锦鸡儿、重量份数为290-310的鸡血藤、重量份数为250-270的丹参、重量份数为250-270的当归、重量份数为190-210的西洋参、重量份数为290-310的熟地、重量份数为140-160的田三七、重量份数为250-270的石斛、重量份数为290-310的石楠叶、重量份数为190-210的川芎、重量份数为250-270的怀牛膝、重量份数为140-160的土鳖虫、重量份数为140-160的地龙、重量份数为90-110的水蛭、重量份数为190-210的白芥子、重量份数为290-310的葛根、重量份数为26000-28000的纯粮酒、重量份数为2400-2600的冰糖。
所述的健脑通络酒,其组成包括重量份数为300的常青藤、重量份数为300的毛冬青、重量份数为300的锦鸡儿、重量份数为300的鸡血藤、重量份数为260的丹参、重量份数为260的当归、重量份数为200的西洋参、重量份数为300的熟地、重量份数为150的田三七、重量份数为260的石斛、重量份数为300的石楠叶、重量份数为200的川芎、重量份数为260的怀牛膝、重量份数为150的土鳖虫、重量份数为150的地龙、重量份数为100的水蛭、重量份数为200的白芥子、重量份数为300的葛根、重量份数为27000的纯粮酒、重量份数为2500的冰糖。
所述的健脑通络酒的制备方法,按上述各组分的重量份数比准备材料,精选除杂后按如下步骤进行制备:
(1)白芥子洗净晾干,用文火炒至深黄色,有爆裂声,并发出香辛味时,停火取出待用;通过加热炒爆使白芥子所含介子酸酶受破坏;
(2)将常青藤、毛冬青、锦鸡儿、鸡血藤、丹参、当归、西洋参、熟地、田三七、石斛、石楠叶、川芎、怀牛膝、土鳖虫、地龙、水蛭、葛根和炮制后的白芥子,碎为粗末,装入若干个用绢或包布制成的袋中,并放入容器中待制;
(3)采用“冷浸法”制作:投入上述组分总质量6倍的纯粮酒加入容器中进行冷浸,每日摇晃4~5次,便于药材中有效成份释放入酒中,浸10日后,放入冰糖红糖,浸后21日即滤出药液,药渣进行压挤,将压挤出液汁与滤液合并,静置五日后过滤出澄清酒药,装瓶待用。
本发明的有益效果:
1.本健脑通络酒的主旨是防患于未然。本健脑通络酒可益气养血、补肾精、滋肾阴同时温督补肾阳,平衡阴阳,化痰通窍,疏导散瘀,改善组织供血作用,达到血滞者可行,血瘀者可解,血栓者可溶,梗塞者可通,其功甚显。
本健脑通络酒适应中风先兆的群体。《缺血性脑血管病》(中风)从古至今,多是治重于预防,言治者多,言防者少。常言道:“病发而治,难求完璧”能不落后遗症者甚稀。多年临床观察,凡中风先兆者服用“健脑通络酒药”六月以上85%以上患者,通过彩超发现颈动脉,脑动脉及冠状动脉壁上脂质斑块可缩小50%~60%以上,血管恢复弹性,血流通畅,继服,可完全避免“缺血性脑血管病”(中风)的发生,并且气血得调、肝肾得补、脾胃得健,精力旺盛,换得身心健康。
本健脑通络酒的组方解析如下所述:
缺血性脑血管病,是神经系统中常见的疾病,在老年人中与心脏病、癌症成为三大主要死因之一。由于血管内血液供应减少,如血栓形成、栓塞等导致脑组织缺血形成梗塞。根据缺血程度的不同,可以有不同的临床表现,如短暂性缺血发作、脑血栓形成、脑栓塞、腔隙性梗塞脑出血等。脑出血是病死率最高。缺血性脑血管病。大多留下中风后遗半身不遂、言语不利、口眼歪斜等,是由风痰流窜经络,络脉痹阻,血瘀气滞,经络不通,气不能行,血不能荣而致。
本健脑通络酒配伍功能:柔肝熄风、潜阳育阴、清火化痰、疏通经络、活血化瘀。全方突出补虚,补脑荣脑、益肝补肾,醒脾和胃、补气血调营卫。服用健脑通络酒能化脂溶栓对已出现轻度或重度中风光兆的群体,心脑血管系统得到修复,使颈动脉、脑动脉及冠状动脉的血管畅通。避免脑血栓、脑栓塞、脑出血等缺血性脑血管病发生。在长期临床实践的基础上经过反复筛选。本健脑通络酒在组方上,充分考虑到中风及其先兆证的发病机制,一般多归纳为虚、火、痰、风、气、血六喘。认为肝肾阴亏或元气虚损为其病理基础。血瘀乃为其发病关键环节。精血不足、脉道不通,血涩不行必成血瘀。瘀重阻络,瘀重致栓塞。中风先兆证成矣。
方中:西洋参既是名贵上品中药又是高级滋补佳品,它含有人体必须的16种微量元素和17种以上氨基酸和多糖、多肽及多种维生素等。临床上防治心脑血管疾病上具有四大功能:1、抗心律失常;2、抗心肌缺血;3、抗心肌氧化;4调节血压。十八味组方药是本健脑通络酒多年通过临床筛选药材。丹参苦寒清泄走心肝血分而清血凉血,活血化瘀,调经止痛,亦能养心安神,能改善冠脉循环,增加冠脉流量,使微循环血流量加快。活血化瘀、溶栓是治疗心脑血管不可多得之佳品。以上两参合力为君药。三七是止血活血,祛瘀通络之要药,和营止血,通脉行瘀。行瘀血而敛新血。一切瘀血皆破、一切新血皆止,化瘀血而不伤新血,三七还能加强侧支循环和改善微循环,使心脑血管缺血较快恢复。当归补血养血,熟地、石斛、石楠叶补肾精滋肝阴,振奋督脉。鸡血藤能扩张冠脉及外周血管,增强血流量,抗凝血,调节血压。毛冬青、锦鸡儿、常青藤是近几年采用之新药,共有除风湿,通经络、破瘀血、消痰湿、降血脂、溶栓塞的功能。多年临床证明是防治脑血栓形成不可缺一的效药。川芎、白芥子、水蛭、葛根,在治疗脑血管病时,临床上经常四药合用,收效较著,有补血和血、活血化瘀,扩张血管之功。川芎辛温香窜、走而不守,能上行颠顶,下达血海,外彻皮毛,旁通四肢,为血中气药,可活周身血,可散全身瘀。水蛭善破瘀血不伤新血,溶栓力宏。白芥子去隔膜之痰,有畅达气机化痰通窍之功。至于葛根借其气轻浮之升阳作用,鼓舞胃气上升而宣通清窍的脉络,扩张血管,改善脑血循环。地龙、土元、牛膝搜风剔邪、逐痰祛瘀、通络、清热熄风、通络止痉、破瘀血、消癥瘕力强。牛膝益肾活血、壮腰膝、疗痿软,引血下行,降上炎之火。全方齐奏,豁痰通络,活血化瘀以使顽痰死血尽去,栓解脂溶,使之心舒气爽,脑清神怡。全方细于治,寓于防组成。
本健脑通络酒中的酒有协同作用,可以提高疗效。而酒本身就有保健作用。它能促进人的胃肠分泌。帮助消化吸收。增强血液循环、促进组织代谢,增强细胞活力。中医认为其性热、走而不守,既有调和气血,贯通脉络之功,又有振阳除寒,祛湿散风之效。《汉书·食货志》赞之为“百药之长”。
酒还是一种良好的有机溶媒,其主要成分乙醇,有良好的穿透性,易于进入药材组织细胞中,可以把中药里大部分水不能溶解,需要非极性溶解的有机物质,酒可以溶解出来,能更好地发挥中药材原有的功能,服后可借酒宜行药势之力,促进本健脑通络酒医治心脑血管疾病的药物疗效最大程度的迅速发挥。
具体实施方式:
实施例1:
一种健脑通络酒,其组成包括常青藤300g、毛冬青300 g、锦鸡儿300 g、鸡血藤300 g、丹参260 g、当归260 g、西洋参200 g、熟地300 g、田三七150 g、石斛260 g、石楠叶300 g、川芎200 g、怀牛膝260 g、土鳖虫150 g、地龙150 g、水蛭100 g、白芥子200 g、葛根300 g、纯粮酒27kg、冰糖2.5kg。
实施例2:
上述健脑通络酒的制备方法是:
(1)十八味药除去土尘灰浊进行精选;
(2)白芥子洗净晾干。用文火炒至深黄色,有爆裂声,并发出香辛味时,停火取出待用。通过加热炒爆使其所含介子酸酶受破坏。可缓解其辛燥之性,以免助热伤阴。并易于侵出药性。
(3)将精选炮制后十八味饮片,碎为粗末,装入若干个用绢或包布制成装袋中,纳入容器中待制。
(4)采用“冷浸法”制作:投入药量6倍纯粮酒加入容器中进行冷浸。每日摇晃4~5次,便于药材中有效成份释放入酒中,浸10日后,放入冰糖红糖。浸后21日即滤出药液,药渣进行压挤,将压挤出液汁与滤液合并。静置五日后过滤出澄清酒药,装瓶待用。
实施例4:
根据实施例1所述的健脑通络酒,组方药材性味、功能、疗效如下:
西洋参:
西洋参味甘,性寒。功能作用抗心律失常、抗心肌缺血、抗心肌氧化、能够抵抗心肌氧化,强化心肌收缩能力。还可以调节血压,对血压可以起到很好的调节作用,可有效降低暂时性的持久性血压,降血压,有助于高血压、心律失常、冠心病、多种心脏疾病,急性心肌梗塞、脑血栓等疾病的恢复。西洋参能提高免疫力。作为补气保健首选药材,可以很好地补气养血,可以促进血清蛋白合成、骨髓蛋白合成、对蛋白的合成起到促进作用。(器官蛋白合成)提高机体免疫力,抑制癌细胞生长,有效抵制癌症。西洋参既是名贵上品中药,又是高级滋补佳品。它含有人体必须的16种微量元素和17种以上氨基酸和多糖、多肽及多种维生素等。具有抗癌、抗疲劳、抗缺氧、抗辐射、抗衰老等多种功能,对冠心病、高血压、贫血、神经官能症、糖尿病等具有很好疗效。
丹参:
味苦性微寒。归心、肝经。功能:改善冠脉循环能扩张心脏冠状动脉并能增加冠脉流量。减轻心肌缺血的损伤并能加速心肌缺血的恢复。改善微循环使微循环血流量显著加快,毛细血管网开放数目增多。并能抑制心肌收缩,减少能量消耗而不损伤心肌。主治:肺心病、冠心病、心绞痛、急性心肌梗死、脑血管病。
常青藤:
性温,味甘、涩。根茎可入药,祛风湿,通经络,止血。有破淤血、活筋止血、消肿毒之功效。果可酿酒。功能主治:祛风通络,活血解毒。用于风湿关节痛,外用跌打损伤、痈疖肿毒。《江西中药》:活血祛风。几筋骨疼痛,及妇人赤白带下等凡由于血滞者,皆主治之。祛风止痛,适用于关节风湿,腰脚软弱、偏瘫等症。
毛冬青:
毛冬青味甘微苦,性温。通常应用脑血栓疾病,可以缩短疗程,使病体恢复比较完全。毛冬青对心绞痛有较好疗效,治疗心肌梗塞有阻止心脏异位节律点兴奋的作用,能减少或消除心律紊乱,保持心脏的正常节律,使心脏排出血量维持良好水平,从而保持良好血压,阻止休克的心力衰竭的发生。促进胸闷痛、头痛、头晕、四肢麻木等临床症状消失或显著改善。毛冬青除有扩张血管,促进血液循环的作用外,对已感染的创面尚有一定的抗菌消炎作用。
锦鸡儿:
味苦、性辛、平。功能:活血通脉,调经、清肺益脾、补肾益气、祛风除湿。降压明显、降低血液黏度,对高血压伴有心肌损害的患者既降压又可改善异常心电使其恢复正常。主治:高血压、气短、心悸、浮肿、虚损劳热、咳嗽、头昏眩晕。
鸡血藤:
鸡血藤味苦微甘,性温。有补血活血、舒筋通络的作用,可治血虚萎黄、月经不调、经闭腹痛,以及腰膝酸痛、筋骨麻木、风湿痹痛等症。对心脏有抑制作用,能扩张冠脉,增加血流量,降血压能扩张外周血管,镇静、催眠、抗凝。
熟地黄:
性味功用:甘、微温。养血补肝肾。清热凉血,生津。成分药理含辛醇甙(Catalpol)、多种糖、多种氨基酸、β-谷兹醇、豆兹醇等。熟地黄有降血糖,利尿作用。熟地黄还能促进淋巴细胞转化,并有增强白细胞及血小板的作用,提高免疫机能。主治应用:(1)治疗肾阴不足,低热盗汗,消渴,手足心热。(2)阴虚火旺,骨蒸潮热,口干舌燥。(3)肝血不足,心悸失眠,眩晕,贫血。(4)血热出血、咯血、吐血、衄血。(5)晚期肿瘤患者有阴虚、肝肾不足及血虚者。
当归:
当归味甘、辛,性温。入心、肝、脾经。本品辛甘温润,以甘温和血,辛温散寒,为血中气药。它既补血、养血,又能柔肝止痛、活血止痛,用于治疗血虚所引起的头昏、目眩、心悸、疲倦、脉细等症;又能治疗月经不调、闭经、痛经,以及跌打损伤、风湿痹痛。对冠心病心绞痛、血栓闭塞性脉管炎、浅部血栓性静脉炎等病症有直接改善的的作用。另外,它还能养血润燥、滑肠通便。用于治疗阴血虚少所引起的肠燥便秘。
三七:
性温,味甘、微苦。有滋补强壮,治血化瘀,消肿止痛的功能。用于治疗气血虚弱、胸腹刺痛、跌打损伤、肿痛、产后瘀阻、崩漏、经闭、内出血、胃和十二指肠溃疡、咯血、吐血、尿血及鼻衄等。【药理作用】三七的药理作用非常广泛,对机体多个系统都有影响,与人参同样被誉为“适应原样”的药物。三七素有“止血之神药”之说,兼能活血散瘀,故有“止血不留瘀”、“活营止血,通脉行瘀”的特点促进凝血酶的生成,使局部血管收缩,增加血小板数等。三七具有良好的止血和活血化瘀之双向调节功能,其止血而不留瘀,化瘀而不伤血,能改善血液“浓、黏、聚、凝”状态,对心血管系统有修复治疗抗冠心病作用,三七或三七的各种制剂对冠心病、心绞痛都有明显疗效。它能通过增加冠脉血流量,改善心肌微循环,从而调整心肌缺血缺氧状态,再加上三七有活血化瘀作用等诸多因素,则是三七抗冠心病作用的药理学基础。三七能加强侧支循环和改善微循环。心肌缺血的变化能较快地恢复,三七有效成分可增加心肌营养性血流量。减少心肌细胞缺血损伤时细胞内酶的释放,对心肌细胞缺血性损伤具有直接的保护作用。三七能扩张血管,产生降压作用。抗心律失常,三七有效成分对多种心律失常有对抗作用。对房颤或房扑,也有明显的改善作用。三七及三七有效成分可降低自发性活动,增强中枢神经的镇静达到催眠、安定、抗惊厥作用。对急性脑缺血后细胞有较明显的保护作用。
石斛:
石斛味甘、淡,性微寒。入肺、胃、肾经。既能养胃阴、生津液、清虚热、止烦呕,用于治疗胃阴不足、虚火上炎所致的烦渴、干呕、饮食乏味、胃脘疼痛、舌干而红,或光剥无苔等症;也治热病后期,阴液亏损、虚热微烦、口干口渴、食欲不振、自汗等症;又能涩元气、强腰膝、坚筋骨,用于治疗腰膝酸软无力、、阴囊潮湿、精少、小便余沥症。
石楠叶:
石楠叶肾衰脚弱,风淫湿痹,堪为妙药。石楠叶味辛苦,性平。有补肾、强腰膝和除风湿的作用,是治疗肾虚腰膝软弱和风湿痹痛等症的好药。应用:治肾虚而兼有风湿麻木,腰背痠痛,脚弱乏力者。
川芎:
川芎味辛,性温。入肝、胆心包经。本品辛温香窜,走而不守,能上行颠顶(头顶),下达血海,外彻皮毛,旁通四肢,为血中之气药。故有活血行气、祛风止痛之功,用于治疗冠心病心绞痛、妇女月经不调、经闭、痛经、难产、胞衣不下,以及头痛,目痛、跌打损伤、疮疡肿痛、风湿痹痛等症。
伍用功能:川芎辛温香窜,行气活血,祛风止痛,散瘀止痛之力较强。
牛膝:
【性味、归经】苦、酸,平。入肝、肾经。【功效】活血祛瘀,引血下行,利尿通淋,补肝肾。【主治】用于产后瘀血腹痛及跌打损伤等。能引血下行以降上炎之火。利尿通淋。牛膝长于补肝肾,强腰膝疗痿弱之证。
土鳖虫
味咸,性寒。有小毒。入肝经。本品既能破瘀血、消肿快、通经闭,用于治疗血滞经闭、月经不调、癥瘕积聚、产后瘀血腹痛等症;又可逐瘀止痛、接骨续筋,用于治疗骨伤筋痛等症。
地龙
味咸,性寒。入肝、脾、膀胱经。本品既能肃肺平喘、息风止痉,用于治疗肺热咳喘、哮喘(支气管哮喘)、小儿痉咳、痰鸣声嘶(相当于痉挛性支气管炎),以及高热烦躁、惊痫、抽搐等证;又能祛风清热、通络止痛,用于治疗热痹所致的关节红肿热痛,以及寒湿痹痛、肢体屈伸不利等症;还能治疗气虚血滞、经络不利所引起的半身不遂,以及跌打损伤、气血不畅、淤积疼痛,尤宜用于急性腰背损伤疼痛和腰腿痛等;还能清热利尿,用于治疗热结膀胱所引起的小便不利,或尿闭不通,或慢性肾炎所引起的小便不畅。另外,可清热降压,用于治疗高血压病,症属肝阳上亢者。地龙咸寒,以下行为主,清热息风,通络止痉。
水蛭:
水蛭性味功用咸、苦,平,有小毒。破血祛瘀,消癥散积。成分药理水蛭的唾腺中含水蛭素,是一种多肽,由多种氨基酸组成。水蛭素是凝血酶抑制剂,有抗凝血作用。对血栓形成有预防作用,此外还含有肝素、抗血栓素等。主治应用:闭经,癥瘕,积聚,跌打损伤,瘀血作痛。《本经》:“主遂恶血、淤血、月闭,破血,瘕聚,……。”本品破血攻淤之力较强,有显著的抗凝作用。
白芥子:
味辛,性温。入肺经。本品辛散温通而利气,既能温肺开胃、利气祛痰、消肿止痛,用于治疗寒痰咳喘、胸闷胁胀、咳吐白痰等症。朱丹溪说:“痰在胁下及皮里膜外,非白芥子莫能达。”还能温通经络、利气散结、祛经络之痰,用于治疗痰湿阻滞经络所引起的肢体关节疼痛、麻木,以及阴疽流注等症。白芥子辛能入肺,温可散寒,长于利气豁痰,温中散寒,通络止痛。专化寒痰滞于胸胁,并能消肿止痛。治痰注肢体关节疼痛,麻利不利。
葛根:
葛根解表退热,生津,透疹,升阳止泻。用于外感发热头痛、高血压颈项强痛、口渴、消渴、麻疹不透、热痢、泄泻。提高肝细胞的再生能力,恢复正常肝脏机能,促进胆汁分泌,防止脂肪在肝脏堆积。促进新陈代谢,加强肝脏解毒功能,防止酒精对肝脏的损伤。能改善高血脂形成的冠状动脉硬化、改善心肌缺血状态,防治冠心病、心绞痛、心肌梗塞等心血管疾病。对高血脂形成的脑动脉硬化,通过改善脑缺血状态,防治脑梗塞、偏瘫、血管性痴呆等脑血管疾病。强化肝胆细胞自身免疫功能,抵抗病毒入侵。
Claims (3)
1.一种健脑通络酒,其特征是:其组成包括重量份数为290-310的常青藤、重量份数为290-310的毛冬青、重量份数为290-310的锦鸡儿、重量份数为290-310的鸡血藤、重量份数为250-270的丹参、重量份数为250-270的当归、重量份数为190-210的西洋参、重量份数为290-310的熟地、重量份数为140-160的田三七、重量份数为250-270的石斛、重量份数为290-310的石楠叶、重量份数为190-210的川芎、重量份数为250-270的怀牛膝、重量份数为140-160的土鳖虫、重量份数为140-160的地龙、重量份数为90-110的水蛭、重量份数为190-210的白芥子、重量份数为290-310的葛根、重量份数为26000-28000的纯粮酒、重量份数为2400-2600的冰糖。
2.根据权利要求1所述的健脑通络酒,其特征是:其组成包括重量份数为300的常青藤、重量份数为300的毛冬青、重量份数为300的锦鸡儿、重量份数为300的鸡血藤、重量份数为260的丹参、重量份数为260的当归、重量份数为200的西洋参、重量份数为300的熟地、重量份数为150的田三七、重量份数为260的石斛、重量份数为300的石楠叶、重量份数为200的川芎、重量份数为260的怀牛膝、重量份数为150的土鳖虫、重量份数为150的地龙、重量份数为100的水蛭、重量份数为200的白芥子、重量份数为300的葛根、重量份数为27000的纯粮酒、重量份数为2500的冰糖。
3.一种权利要求1或2所述的健脑通络酒的制备方法,其特征是:按上述各组分的重量份数比准备材料,精选除杂后按如下步骤进行制备:
(1)白芥子洗净晾干,用文火炒至深黄色,有爆裂声,并发出香辛味时,停火取出待用;通过加热炒爆使白芥子所含介子酸酶受破坏;
(2)将常青藤、毛冬青、锦鸡儿、鸡血藤、丹参、当归、西洋参、熟地、田三七、石斛、石楠叶、川芎、怀牛膝、土鳖虫、地龙、水蛭、葛根和炮制后的白芥子,碎为粗末,装入若干个用绢或包布制成的袋中,并放入容器中待制;
(3)采用“冷浸法”制作:投入上述组分总质量6倍的纯粮酒加入容器中进行冷浸,每日摇晃4~5次,便于药材中有效成份释放入酒中,浸10日后,放入冰糖红糖,浸后21日即滤出药液,药渣进行压挤,将压挤出液汁与滤液合并,静置五日后过滤出澄清酒药,装瓶待用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710509863.5A CN107158249A (zh) | 2017-06-28 | 2017-06-28 | 健脑通络酒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710509863.5A CN107158249A (zh) | 2017-06-28 | 2017-06-28 | 健脑通络酒及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107158249A true CN107158249A (zh) | 2017-09-15 |
Family
ID=59827023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710509863.5A Pending CN107158249A (zh) | 2017-06-28 | 2017-06-28 | 健脑通络酒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107158249A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112843121A (zh) * | 2019-11-28 | 2021-05-28 | 中国中医科学院中医临床基础医学研究所 | 一种皂角子的炮制方法 |
-
2017
- 2017-06-28 CN CN201710509863.5A patent/CN107158249A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112843121A (zh) * | 2019-11-28 | 2021-05-28 | 中国中医科学院中医临床基础医学研究所 | 一种皂角子的炮制方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN107693767A (zh) | 一种防治糖尿病足的外用中药组合物、其制备方法及应用 | |
CN104206594A (zh) | 一种降压降脂的桑寄生保健茶及其制备方法 | |
CN103749824B (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN103990079A (zh) | 用于治疗气滞血瘀型腰肌劳损的药物组合物及其制备方法 | |
CN102174362B (zh) | 一种黄精保健酒及其制备方法 | |
CN106389881A (zh) | 一种活血散瘀膏 | |
CN103494866A (zh) | 一种治疗腰腿疼的组配方法 | |
CN105687788A (zh) | 一种软化血管的药物组合物及其应用 | |
CN107158249A (zh) | 健脑通络酒及其制备方法 | |
CN105012873A (zh) | 一种降血脂的月见草保健口服液及其制备方法 | |
CN102048939B (zh) | 一种治疗窦性心动过缓药物 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN104026295B (zh) | 一种降血压血糖保健茶 | |
CN106729518A (zh) | 一种降血压的茶饮料及其制备方法与应用 | |
CN104906399A (zh) | 一种治疗心脏病的中药丸剂及其制备方法 | |
CN104840686A (zh) | 一种降压保健茶 | |
CN104606571A (zh) | 一种生津止渴鲜菠菜根代茶饮及制备方法 | |
CN104189615B (zh) | 一种治疗崩漏的中药制剂及其制备方法 | |
CN107375702A (zh) | 一种用于治疗高血压的中药组合物 | |
CN106389663A (zh) | 一种含有党参治疗痛风的排酸茶 | |
CN105125886A (zh) | 一种用于预防和治疗糖尿病及其并发症的中药组合物 | |
CN104721741A (zh) | 一种治疗虚寒型血栓性静脉炎的药物及其制备方法 | |
CN104799276A (zh) | 一种麻七利血溶栓粉及其制备方法 | |
CN104399057A (zh) | 一种治疗淤滞型血栓性静脉炎的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170915 |
|
WD01 | Invention patent application deemed withdrawn after publication |